Advanced Cancer: BI 1831169 and Anti-PD-1 Therapy

We are testing different doses of a new medication alone and with an anti-PD-1 antibody for people with advanced solid tumors. This study aims to see how well these treatments work together.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medizinische Universitaet Innsbruck
Univ.-Klinik für Innere Medizin V, Hämatologie und Onkologie
Innsbruck, Austria
SCRI CCCIT Ges.m.b.H.
Center for Clinical Cancer and Immunology Trials (CCCIT)
Salzburg, Austria
UZ Leuven
General Medical Oncology
Heverlee, Belgium

Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.